Pharmaceutical companies heavily rely on patents as their main vehicle to protect intellectual property.
drug patent regulations
May 14, 2021 8:58AM
August 6, 2020 11:37AM
Strong intellectual property rights are crucial for expediting clinical trials for preventive vaccines.
November 19, 2018 11:19AM
Rather than write and debate legislation, politicians increasingly leave the difficult work of legislating to bureaucrats.
July 20, 2018 1:00AM
October 12, 2016 4:00AM
Diseases such as rabies, malaria and leprosy still afflict many in less-developed countries.
July 17, 2003 2:00AM
Before breaking for the summer, the House of Commons Standing Committee on Industry, Science, and Technology considered weakening the patent regulations that support Canadas pharmaceutical market. Now, prompted by public-sector unions, the Competition Bureau will look at whether pharmaceutical patents are anti-competitive. These investigations have only one result: to harm international investors confidence in Canadas will to protect intellectual property. Furthermore, history suggests that if they succeed in weakening patents, drug costs are unlikely to come down.